Catherine Bagot

3.7k total citations · 1 hit paper
46 papers, 2.0k citations indexed

About

Catherine Bagot is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Catherine Bagot has authored 46 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 9 papers in Internal Medicine and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Catherine Bagot's work include Platelet Disorders and Treatments (12 papers), Hemophilia Treatment and Research (12 papers) and Blood Coagulation and Thrombosis Mechanisms (10 papers). Catherine Bagot is often cited by papers focused on Platelet Disorders and Treatments (12 papers), Hemophilia Treatment and Research (12 papers) and Blood Coagulation and Thrombosis Mechanisms (10 papers). Catherine Bagot collaborates with scholars based in United Kingdom, United States and France. Catherine Bagot's co-authors include Roopen Arya, Hugh S. Taylor, Patrick Troy, Gaurang S. Daftary, Marie Scully, Will Lester, Sue Pavord, Beverley J. Hunt, Μichael Μakris and Brian Craven and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Catherine Bagot

42 papers receiving 2.0k citations

Hit Papers

Clinical Features of Vaccine-Induced Immune Thrombocytope... 2021 2026 2022 2024 2021 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis
    2021 364 citations Marie Scully, Will Lester et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Bagot United Kingdom 18 752 477 414 412 328 46 2.0k
P. Marès France 29 1.3k 1.8× 300 0.6× 254 0.6× 724 1.8× 231 0.7× 185 3.4k
Maha Othman Canada 26 1.3k 1.8× 275 0.6× 263 0.6× 347 0.8× 30 0.1× 147 2.5k
Éric Mercier France 24 1.2k 1.5× 382 0.8× 252 0.6× 133 0.3× 57 0.2× 61 2.0k
Lynne Uhl United States 23 829 1.1× 861 1.8× 181 0.4× 375 0.9× 58 0.2× 69 2.2k
Michael K. Bohlmann Germany 24 135 0.2× 306 0.6× 46 0.1× 320 0.8× 540 1.6× 118 1.7k
John Lazarchick United States 25 883 1.2× 231 0.5× 147 0.4× 285 0.7× 16 0.0× 135 2.0k
O. Fain France 37 815 1.1× 888 1.9× 20 0.0× 413 1.0× 160 0.5× 203 4.2k
Rendrik F. Franco Brazil 27 1.2k 1.6× 290 0.6× 388 0.9× 225 0.5× 10 0.0× 63 2.1k
Jun Yoshimatsu Japan 25 178 0.2× 282 0.6× 59 0.1× 354 0.9× 61 0.2× 139 2.3k
Olivier Fain France 30 925 1.2× 584 1.2× 42 0.1× 425 1.0× 22 0.1× 124 2.7k

Countries citing papers authored by Catherine Bagot

Since Specialization
Citations

This map shows the geographic impact of Catherine Bagot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Bagot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Bagot more than expected).

Fields of papers citing papers by Catherine Bagot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Bagot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Bagot. The network helps show where Catherine Bagot may publish in the future.

Co-authorship network of co-authors of Catherine Bagot

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Bagot. A scholar is included among the top collaborators of Catherine Bagot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Bagot. Catherine Bagot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kavaklı, Kaan, Adam Cuker, Laurent Frenzel, et al.. (2025). Health-related quality of life in adults with hemophilia B after gene therapy with fidanacogene elaparvovec: results from the BENEGENE-2 trial. Journal of Thrombosis and Haemostasis. 24(1). 132–145.
2.
Kenet, Gili, Beatrice Nolan, Bülent Zülfikar, et al.. (2024). Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial. Blood. 143(22). 2256–2269. 16 indexed citations
3.
Leebeek, Frank W.G., Karin Fijnvandraat, Michiel Coppens, et al.. (2023). A new population pharmacokinetic model for recombinant factor IX‐Fc fusion concentrate including young children with haemophilia B. British Journal of Clinical Pharmacology. 90(1). 220–231. 3 indexed citations
4.
Martin, Jill, et al.. (2023). Fibrinogenolysis and fibrinolysis in vaccine-induced immune thrombocytopenia and thrombosis. Journal of Thrombosis and Haemostasis. 21(12). 3589–3596. 5 indexed citations
5.
Srivastava, Alok, Savita Rangarajan, Kaan Kavaklı, et al.. (2023). Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial. The Lancet Haematology. 10(5). e322–e332. 51 indexed citations
6.
Scully, Marie, R. Rayment, Amanda Clark, et al.. (2023). A British Society for Haematology Guideline: Diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies. British Journal of Haematology. 203(4). 546–563. 22 indexed citations
7.
Doyle, Andrew J., Matthew Stubbs, Tina Dutt, et al.. (2022). Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy. Blood. 141(3). 285–294. 10 indexed citations
8.
Coppens, Michiel, Samantha C. Gouw, Sara Boyce, et al.. (2022). Desmopressin for bleeding in non‐severe hemophilia A: Suboptimal use in a real‐world setting. Research and Practice in Thrombosis and Haemostasis. 6(6). e12777–e12777. 7 indexed citations
9.
Whyte, Claire S., Gael B. Morrow, Carol Wallace, et al.. (2022). The suboptimal fibrinolytic response in COVID‐19 is dictated by high PAI‐1. Journal of Thrombosis and Haemostasis. 20(10). 2394–2406. 39 indexed citations
10.
Boyce, Sara, Savita Rangarajan, Nicola Curry, et al.. (2022). Seroprevalence to adeno‐associated virus type 6 in people with hemophilia B from a UK adult cohort. Research and Practice in Thrombosis and Haemostasis. 6(4). e12705–e12705. 6 indexed citations
11.
Bagot, Catherine, Erik A.M. Beckers, Giancarlo Castaman, et al.. (2022). The bleeding phenotype in people with nonsevere hemophilia. Blood Advances. 6(14). 4256–4265. 17 indexed citations
12.
13.
Pasi, John, Toshko Lissitchkov, Vasily Mamonov, et al.. (2021). Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort. Journal of Thrombosis and Haemostasis. 19(6). 1436–1446. 69 indexed citations
14.
15.
16.
Bagot, Catherine & Emma Leishman. (2015). Establishing a reference range for thrombin generation using a standard plasma significantly improves assay precision. Thrombosis Research. 136(1). 139–143. 15 indexed citations
17.
Bagot, Catherine & Roopen Arya. (2008). Virchow and his triad: a question of attribution. British Journal of Haematology. 143(2). 180–190. 404 indexed citations
18.
Cross, Timothy, et al.. (2006). Imatinib mesylate as a cause of acute liver failure. American Journal of Hematology. 81(3). 189–192. 59 indexed citations
19.
Bagot, Catherine, Harvey J. Kliman, & Hugh S. Taylor. (2001). Maternal Hoxa10 is required for pinopod formation in the development of mouse uterine receptivity to embryo implantation. Developmental Dynamics. 222(3). 538–544. 102 indexed citations
20.
Bagot, Catherine, Patrick Troy, & Hugh S. Taylor. (2000). Alteration of maternal Hoxa10 expression by in vivo gene transfection affects implantation. Gene Therapy. 7(16). 1378–1384. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Marès Breakdown of academic impact, for papers by Maha Othman Breakdown of academic impact, for papers by Éric Mercier Breakdown of academic impact, for papers by Lynne Uhl Breakdown of academic impact, for papers by Michael K. Bohlmann Breakdown of academic impact, for papers by John Lazarchick Breakdown of academic impact, for papers by O. Fain Breakdown of academic impact, for papers by Rendrik F. Franco Breakdown of academic impact, for papers by Jun Yoshimatsu Breakdown of academic impact, for papers by Olivier Fain
Rankless by CCL
2026